Thermoluminescent chip detector for in vivo dosimetry in pelvis and head & neck cancer treatment

Marcela A Leal; Claudio Viegas; Alfredo Viamonte; Anna Campos; Delson Braz; Paul Clivland

doi:10.1016/j.apradiso.2009.12.027

Thermoluminescent chip detector for in vivo dosimetry in pelvis and head & neck cancer treatment

Appl Radiat Isot. 2010 Apr-May;68(4-5):795-8. doi: 10.1016/j.apradiso.2009.12.027. Epub 2009 Dec 21.

Authors

Marcela A Leal¹, Claudio Viegas, Alfredo Viamonte, Anna Campos, Delson Braz, Paul Clivland

Affiliation

¹ Nuclear Instrumentation Laboratory-COPPE/UFRJ, Rio de Janeiro, Brazil. marcelaleal@lin.ufrj.br

PMID: 20133140
DOI: 10.1016/j.apradiso.2009.12.027

Abstract

Our aim is to show the TL dosimetry as a confident QA method for radiotherapy treatments. Before in vivo entrance dose measurements using TLD-100 chips, ECLIPSE TPS-simulated treatments for a Rando anthropomorphic phantom, two for pelvis and one head & neck. In Vivo measurements results with (60)Co beam remained within +/-5% limits. Results for 6 and 15 MV are in conclusion. This is a National Cancer Institute/RJ/Brazil study under the 13.111-IAEA Coordinated Research Project.

Publication types

Evaluation Study
Research Support, Non-U.S. Gov't

MeSH terms

Equipment Design
Equipment Failure Analysis
Head and Neck Neoplasms / radiotherapy*
Humans
Pelvic Neoplasms / radiotherapy*
Radiotherapy Dosage
Radiotherapy, Conformal / instrumentation*
Reproducibility of Results
Sensitivity and Specificity
Thermoluminescent Dosimetry / instrumentation*
Transducers*